FDA Clears Affymetrix Gene Profiling Reagents

The clearance of the gene expression reagents makes Affymetrix the first firm to provide a "comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives," it said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories